NEW DELHI: The Indian Patent Office has rejected the grant of a patent for dolutegravir , a crucial HIV drug marketed by Viiv Healthcare , facilitating the entry of generics and expanding access to affordable, life-saving treatment. The decision, announced after a contentious nearly decade-long battle, follows the company's patent application for the HIV treatment in 2007.
The company faced multiple pre-grant oppositions from Natco and various advocacy groups between 2013 and 2019, according to the order accessed by TOI. It led to the Patent Office rejecting the grant of a patent recently. Experts believe the ruling could serve as an example against the practice of " evergreening " patents, a practice that extends patent life through patenting of obvious forms and improvements of life-saving medicines. Over the next few years, with more players entering the market, the first-line HIV drug will likely be available at a fraction of the innovator price.
"I am of the opinion that claims are not patentable under Section 3(d) of the Act since no enhanced therapeutic efficacy has been demonstrated in the specification," the order by Deputy Controller D Usha Rao said.
Viiv Healthcare, which is majority owned by GSK and has Pfizer and Shionogi as major shareholders, is focused on HIV therapies. In April 2014, the Medicines Patent Pool and ViiV Healthcare signed licensing agreements to accelerate access to dolutegravir, for adult and paediatric care.
The company faced multiple pre-grant oppositions from Natco and various advocacy groups between 2013 and 2019, according to the order accessed by TOI. It led to the Patent Office rejecting the grant of a patent recently. Experts believe the ruling could serve as an example against the practice of " evergreening " patents, a practice that extends patent life through patenting of obvious forms and improvements of life-saving medicines. Over the next few years, with more players entering the market, the first-line HIV drug will likely be available at a fraction of the innovator price.
"I am of the opinion that claims are not patentable under Section 3(d) of the Act since no enhanced therapeutic efficacy has been demonstrated in the specification," the order by Deputy Controller D Usha Rao said.
Viiv Healthcare, which is majority owned by GSK and has Pfizer and Shionogi as major shareholders, is focused on HIV therapies. In April 2014, the Medicines Patent Pool and ViiV Healthcare signed licensing agreements to accelerate access to dolutegravir, for adult and paediatric care.
You may also like
Photo of Jimmy Carter in voting queue viral: 'Elder abuse', 'Criminal and disgusting'
SpiceJet receives 'bomb' threat for two flights on social media handle, pax disembarked
Loose Women legend breaks down in tears as she pays tribute to 'missed' co-star
Tech Hiring: Wanted Million Cloud Professionals in FY25, Check Details Here
DWP will 'directly contact' 120,000 people to claim £3,900 boost - are you eligible?
Maharashtra Assembly Election 2024: Eligible Voters Have 3 More Days To Register, Check Details Here
This Bangalore based company got the contract for bullet train, the train running at 280 kmph will have these facilities
Daniel Ricciardo suggests he's "retired" from F1 in friend's Instagram post
'Dance of death': Bengal governor on Mamata govt's Durga Puja carnival amid doctors' protest
Inside Annie Kilner and Kyle Walker's 'final shot' at embattled marriage before 'collapse'
End-of-life doctor reveals what happens right before you die - and says not to be afraid
Bajaj Auto Q2FY25 Net Profit Jumps 9.2% YoY; Announces $10M Investment In Brazilian Subsidiary
Boeing is about to collapse! The company, which is neck deep in debt, is asking for a loan of billions of dollars
South Korean and Indian companies leverage Dubai as a gateway for global growth opportunities
Popular compost item will 'quickly' attract rats in your garden, warns pest expert
New chip-based blood test can diagnose heart attacks in minutes
Inside Coleen Rooney's I'm A Celebrity stint with record £1.5m deal and hubby Wayne 'worried'
Major update after couple and their dog all found dead at home by horrified daughter
Jharkhand Police seek deployment of 590 paramilitary personnel for Assembly elections
Jharkhand's Healthcare Crisis: Pregnant Woman Gives Birth Outside Hospital, Sparking Outrage